Package: 50T/kit
This lyophilized kit is intended for the in-vitro qualitative detection of RNA from the COVID-19, Influenza A virus (IAV) and Influenza B virus (IBV) and Respiratory Syncytial Virus (RSV) in human oropharyngeal swabs specimens. It is suitable for COVID-19/IAV/IBV/RSV identification and auxiliary diagnosis of infection.
COVID-19 emerged in late 2019, causing a global pandemic. Its symptoms range from asymptomatic or mild (fever, cough, loss of taste/smell) to severe pneumonia, acute respiratory distress syndrome (ARDS), and multi-organ failure.
Influenza causes seasonal epidemics worldwide. Symptoms include sudden onset of fever, myalgia, headache, sore throat, and cough.
RSV is a leading cause of acute lower respiratory tract infections in infants and young children worldwide, often resulting in bronchiolitis and pneumonia. It also causes significant morbidity and mortality in older adults and immunocompromised individuals.
Package: 50T/kit
This lyophilized kit is intended for the in-vitro qualitative detection of RNA from the COVID-19, Influenza A virus (IAV) and Influenza B virus (IBV) and Respiratory Syncytial Virus (RSV) in human oropharyngeal swabs specimens. It is suitable for COVID-19/IAV/IBV/RSV identification and auxiliary diagnosis of infection.
COVID-19 emerged in late 2019, causing a global pandemic. Its symptoms range from asymptomatic or mild (fever, cough, loss of taste/smell) to severe pneumonia, acute respiratory distress syndrome (ARDS), and multi-organ failure.
Influenza causes seasonal epidemics worldwide. Symptoms include sudden onset of fever, myalgia, headache, sore throat, and cough.
RSV is a leading cause of acute lower respiratory tract infections in infants and young children worldwide, often resulting in bronchiolitis and pneumonia. It also causes significant morbidity and mortality in older adults and immunocompromised individuals.
